name: cytoplasmic dynein 1 heavy chain 1 deaminated 1 (human)

description: A cytoplasmic dynein 1 heavy chain 1 (human) that has been deaminated on the residue at the position equivalent to Asn-2067 of the amino acid sequence represented by UniProtKB:Q14204. UniProtKB:Q14204, Asn-2067, MOD:00684.


Recurrent Lymphomatoid Granulomatosis

category: biolink:Disease biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing

description: The reemergence of lymphomatoid granulomatosis after a period of remission.


name: Recurrent Grade II Lymphomatoid Granulomatosis

description: The reemergence of grade II lymphomatoid granulomatosis after a period of remission.


name: Recurrent Grade I Lymphomatoid Granulomatosis

description: The reemergence of grade I lymphomatoid granulomatosis after a period of remission.


name: Recurrent Childhood Lymphomatoid Granulomatosis

description: The reemergence of lymphomatoid granulomatosis in childhood after a period of remission.


retinitis pigmentosa 2

description: Any retinitis pigmentosa in which the cause of the disease is a mutation in the RP2 gene.


RP2-related retinopathy

description: A retinopathy caused by variants in the X-linked gene, RP2.


carbotetracyclic compound

A carbopolyclic compound comprising of four carbocyclic rings.


11H-benzo[a]fluoren-11-ylacetic acid

A carbotetracyclic compound that is 11H-benzo[a]fluorene substituted by a carboxymethyl group at position 11.


R,R-THC

A carbotetracyclic compound that is 5,6,11,12-tetrahydrochrysene substituted by hydroxy groups at positions 2 and 8 and by ethyl groups at positions 5 and 11 (the 5R,11R-stereoisomer). It is an agonist of ER-alpha and antagonist of ER-beta receptors.


1,2-dihydropyrene-2-carboxylic acid

A member of the class of pyrenes that is 1,2-dihydropyrene substituted by a carboxy group at position 2.


name: Extraocular Cutaneous Sebaceous Carcinoma

description: A rare variant of sebaceous carcinoma that does not affect the ocular region.


Conjunctival Sebaceous Carcinoma

description: A rare sebaceous carcinoma that arises from the conjunctiva.


Metastatic Sebaceous Carcinoma

description: Sebaceous carcinoma that has spread from the original site of growth to other anatomic sites.


Recurrent Sebaceous Carcinoma

description: The reemergence of sebaceous carcinoma after a period of remission.


sebaceous carcinoma of salivary gland

description: A rare sebaceous carcinoma that arises from the salivary glands.


Refractory Sebaceous Carcinoma

description: Sebaceous carcinoma that is resistant to treatment.


Head and Neck Sebaceous Carcinoma

description: A sebaceous carcinoma that arises from the head and neck region.


name: YOBB_ECOLI Uncharacterized protein YobB (sprot)

description: An uncharacterized protein YobB that is encoded in the genome of Escherichia coli K-12.


PDPT 28:0

A 1,2-diacyl-phosphatidyldimethylpropanethiol in which the two acyl groups contain a total of 28 carbons and no double bonds.


Diacyl PDPT

A class of glycerophospholipids in which a phosphatidyl group is esterified to the hydroxy group of dimethylpropanethiol.


PDPT 14:0/14:0

A 1,2-diacyl-phosphatidyldimethylpropanethiol in which the two acyl groups both contain 14 carbons and no double bonds (tetradecanoyl).


PDPT 14:0/18:1

A 1,2-diacyl-phosphatidyldimethylpropanethiol in which the two acyl substituents at positions 1 and 2 contain 14 carbons and no double bonds (tetradecanoyl) and 18 carbons and 1 double bond (octadecenoyl) respectively.


PDPT 14:0_18:1

A 1,2-diacyl-phosphatidyldimethylpropanethiol in which one of the acyl groups contains 14 carbons and no double bonds (tetradecanoyl) and the other contains 18 carbons and 1 double bond (octadecenoyl).


PDPT 32:1

A 1,2-diacyl-phosphatidyldimethylpropanethiol in which the two acyl groups contain a total of 32 carbons and 1 double bond.


name: alanine--tRNA ligase, cytoplasmic isoform h2 (human)

description: An alanine--tRNA ligase, cytoplasmic (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P49588-2.


name: SYAC_HUMAN Alanine--tRNA ligase, cytoplasmic (sprot)

description: An alanine--tRNA ligase, cytoplasmic that is encoded in the genome of human.


name: alanine--tRNA ligase, cytoplasmic deaminated 3 (human)

description: An alanine--tRNA ligase, cytoplasmic (human) that has been deaminated on the residue at the position equivalent to Asn-488 of the amino acid sequence represented by UniProtKB:P49588-1. Example: UniProtKB:P49588-1, Asn-488, MOD:00684.


name: alanine--tRNA ligase, cytoplasmic deaminated 1 (human)

description: An alanine--tRNA ligase, cytoplasmic (human) that has been deaminated on the residue at the position equivalent to Asn-55 of the amino acid sequence represented by UniProtKB:P49588-1. Example: UniProtKB:P49588-1, Asn-55, MOD:00684.


name: alanine--tRNA ligase, cytoplasmic isoform 1 (human)

description: An alanine--tRNA ligase, cytoplasmic isoform 1 that is encoded in the genome of human.


name: alanine--tRNA ligase, cytoplasmic deaminated 2 (human)

description: An alanine--tRNA ligase, cytoplasmic (human) that has been deaminated on the residue at the position equivalent to Gln-960 of the amino acid sequence represented by UniProtKB:P49588-1. Example: UniProtKB:P49588-1, Gln-960, MOD:00685.


name: oxytocin-neurophysin 1 isoform 1 (human)

description: An oxytocin-neurophysin 1 isoform 1 that is encoded in the genome of human.


name: AGRF3_HUMAN Adhesion G-protein coupled receptor F3 (sprot)

description: An adhesion G-protein coupled receptor F3 that is encoded in the genome of human.


adhesion G-protein coupled receptor F3

An adhesion G-protein coupled receptor that is a translation product of the human ADGRF3 gene or a 1:1 ortholog thereof.


name: adhesion G-protein coupled receptor F3 isoform h2 (human)

description: An adhesion G-protein coupled receptor F3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8IZF5-2.


name: AGRF3_MOUSE Adhesion G-protein coupled receptor F3 (sprot)

description: An adhesion G-protein coupled receptor F3 that is encoded in the genome of mouse.


name: adhesion G-protein coupled receptor F3 isoform h3 (human)

description: An adhesion G-protein coupled receptor F3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8IZF5-3.


name: adhesion G-protein coupled receptor F3 isoform h1 (human)

description: An adhesion G-protein coupled receptor F3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8IZF5-1.


Tropical Disease

description: Infectious and parasitic diseases endemic in tropical and subtropical zones, including Chagas' disease, leishmaniasis, leprosy, malaria, onchocerciasis, schistosomiasis, sleeping sickness, yellow fever, and others; often water- or insect-borne.


infection by Trypanosoma gambiense

description: Trypanosomiasis caused by infection by Trypanosoma brucei gambiense.


early yaws

description: Early yaws includes primary and secondary stages of yaws, endemic tropical treponemal nonvenereal infection: development of initial lesion at inoculation site followed by widespread dissemination of treponemes and generalized secondary granulomatous lesions that may relapse repeatedly.


infection by Trypanosoma rhodesiense

description: An infection with Trypanosoma brucei rhodesiense.


late yaws

description: Late yaws is the tertiary, non-contagious stage of yaws, endemic tropical treponemal nonvenereal infection. Late yaws is characterized by destructive and deforming lesions of the skin, bones, and joints.


yaws

description: An endemic, infectious, nonvenereal disease in humans that presents mainly in children younger than 15 years. The disease occurs primarily in warm, humid, tropical areas of Africa, Asia, South America, and Oceania, among poor rural populations where conditions of overcrowding and poor sanitation prevail. Infection with Treponema pertenue, a subspecies of Treponema pallidum, causes the disease.


name: POU domain, class 3, transcription factor 3-B isoform Short (zebrafish)

description: A POU domain, class 3, transcription factor 3-B (zebrafish) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P79745-2.


name: proton-activated chloride channel isoform 1

description: A proton-activated chloride channel that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9H813-1 or a 1:1 ortholog thereof.


proton-activated chloride channel

A protein that is a translation product of the human PACC1 gene or a 1:1 ortholog thereof.


name: proton-activated chloride channel isoform 1 (human)

description: A proton-activated chloride channel isoform 1 that is encoded in the genome of human.


name: PACC1_HUMAN Proton-activated chloride channel (sprot)

description: A proton-activated chloride channel that is encoded in the genome of human.


name: PACC1_MOUSE Proton-activated chloride channel (sprot)

description: A proton-activated chloride channel that is encoded in the genome of mouse.


name: transmembrane protein 206 isoform 1 (mouse)

description: A proton-activated chloride channel isoform 1 that is encoded in the genome of mouse.


name: proton-activated chloride channel isoform h2 (human)

description: A proton-activated chloride channel (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9H813-2.


name: transmembrane protein 206 isoform 1 (rat)

description: A proton-activated chloride channel isoform 1 that is encoded in the genome of rat.


name: PACC1_DANRE Proton-activated chloride channel (sprot)

description: A proton-activated chloride channel that is encoded in the genome of zebrafish.


name: PACC1_RAT Proton-activated chloride channel (sprot)

description: A proton-activated chloride channel that is encoded in the genome of rat.


name: HEM62_ARATH Coproporphyrinogen-III oxidase 2, chloroplastic (sprot)

description: A protein that is a translation product of the CPX2 gene in Arabidopsis thaliana.


name: coproporphyrinogen-III oxidase 2, chloroplastic isoform 2 (Arabidopsis thaliana)

description: A coproporphyrinogen-III oxidase 2, chloroplastic (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q93Z96-2.


name: coproporphyrinogen-III oxidase 2, chloroplastic isoform 1 (Arabidopsis thaliana)

description: A coproporphyrinogen-III oxidase 2, chloroplastic (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q93Z96-1.


name: cytoplasmic protein NCK2 isoform 1 (human)

description: A cytoplasmic protein NCK2 isoform 1 that is encoded in the genome of human.


sodium hexacyclonate

A hydroxy monocarboxylic acid that is cyclohexane substituted by a hydroxymethyl and carboxymethyl groups at position 1.


olivetolic acid biosynthetic process

category: biolink:BiologicalProcess biolink:Occurrent biolink:OntologyClass biolink:BiologicalProcessOrActivity biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing biolink:PhysicalEssenceOrOccurrent

description: The chemical reactions and pathways resulting in the formation of olivetolic acid.


name: monocarboxylic acid biosynthetic process

description: The chemical reactions and pathways resulting in the formation of monocarboxylic acids, any organic acid containing one carboxyl (-COOH) group.


description: The chemical reactions and pathways resulting in the formation of 3,4-dihydroxybenzoate.


name: pyruvate biosynthetic process from acetate

description: The chemical reactions and pathways resulting in the formation of pyruvate from other compounds, including acetate.


prostanoid biosynthetic process

description: The chemical reactions and pathways resulting in the formation of prostanoids, any compound based on or derived from the prostanoate structure.


fatty acid elongation

description: The elongation of a fatty acid chain by the sequential addition of two-carbon units.


description: The chemical reactions and pathways resulting in the formation of 3-(3-hydroxyphenyl)propanoate.


pantothenate biosynthetic process

description: The chemical reactions and pathways resulting in the formation of pantothenate, the anion of pantothenic acid. It is a B complex vitamin that is a constituent of coenzyme A and is distributed ubiquitously in foods.


coenzyme B biosynthetic process

description: The chemical reactions and pathways resulting in the formation of coenzyme B (7-mercaptoheptanoylthreonine phosphate), a coenzyme involved in the utilization of methane by methanogenic prokaryotes.


D-gluconate biosynthetic process

description: The chemical reactions and pathways resulting in the formation of D-gluconate, the anion of D-gluconic acid, the aldonic acid derived from glucose.


name: para-aminobenzoic acid biosynthetic process

description: The chemical reactions and pathways resulting in the formation of para-aminobenzoic acid, an intermediate in the synthesis of folic acid, a compound which some organisms, e.g. prokaryotes, eukaryotic microbes, and plants, can synthesize de novo. Others, notably mammals, cannot. In yeast, it is present as a factor in the B complex of vitamins.


ketogluconate biosynthetic process

description: The chemical reactions and pathways resulting in the formation of ketogluconate, the anion of ketogluconic acid, an aldonic acid derived from glucose containing a ketonic carbonyl group.


lipoxin A4 biosynthetic process

description: The chemical reactions and pathways resulting in the formation of lipoxin A4. Lipoxin A4 is a C20 hydroxy fatty acid having (5S)-, (6R)- and (15S)-hydroxy groups as well as (7E)- (9E)-, (11Z)- and (13E)-double bonds.


leukotriene B4 biosynthetic process

description: The chemical reactions and pathways resulting in the formation of leukotriene B4, a leukotriene composed of (6Z,8E,10E,14Z)-eicosatetraenoic acid having (5S)- and (12R)-hydroxy substituents.


acetate biosynthetic process

description: The chemical reactions and pathways resulting in the formation of acetate, the anion of acetic acid.


galacturonate biosynthetic process

description: The chemical reactions and pathways resulting in the formation of galacturonate, the anion of galacturonic acid.


description: The chemical reactions and pathways resulting in the formation of 3-(2,3-dihydroxyphenyl)propanoate.


nicotinate biosynthetic process

description: The chemical reactions and pathways resulting in the formation of nicotinate.


name: (R)-mandelate catabolic process to benzoate

description: The chemical reactions and pathways resulting in the breakdown of (R)-mandelate into other compounds, including benzoate.


pentalenolactone biosynthetic process

description: The chemical reactions and pathways resulting in the formation of pentalenolactone.


name: fatty acid elongation, polyunsaturated fatty acid

description: Elongation of a fatty acid chain into which two or more C-C double bonds have been introduced.


name: (R)-2-hydroxy-alpha-linolenic acid biosynthetic process

description: The chemical reactions and pathways resulting in the formation of (R)-2-hydroxy-alpha-linolenic acid.


keto-D-gluconate biosynthetic process

description: The chemical reactions and pathways resulting in the formation of keto-D-gluconate, the anion of keto-D-gluconic acid, an aldonic acid derived from glucose.


fumagillin biosynthetic process

description: The chemical reactions and pathways resulting in the formation of fumagillin.


benzylpenicillin biosynthetic process

description: The chemical reactions and pathways resulting in the formation of benzylpenicillin.


name: indoleacetic acid biosynthetic process via tryptophan

description: The chemical reactions and pathways resulting in the formation of indole-3-acetic acid that occurs through metabolism of L-tryptophan.


name: D(-)-lactate biosynthetic process from pyruvate

description: The chemical reactions and pathways resulting in the formation of D(-)-lactate from other compounds, including pyruvate.


picolinic acid biosynthetic process

description: The chemical reactions and pathways resulting in the formation of picolinic acid.


fatty acid biosynthetic process

description: The chemical reactions and pathways resulting in the formation of a fatty acid, any of the aliphatic monocarboxylic acids that can be liberated by hydrolysis from naturally occurring fats and oils. Fatty acids are predominantly straight-chain acids of 4 to 24 carbon atoms, which may be saturated or unsaturated; branched fatty acids and hydroxy fatty acids also occur, and very long chain acids of over 30 carbons are found in waxes.


sinapate biosynthetic process

description: The chemical reactions and pathways resulting in the formation of sinapate, (2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate.


mycophenolic acid biosynthetic process

description: The chemical reactions and pathways resulting in the formation of mycophenolic acid (MPA). MPA is the first isolated antibiotic natural product in the world obtained from a culture of Penicillium brevicompactum in 1893.


name: regulation of fever generation by prostaglandin biosynthetic process

description: Any prostaglandin biosynthetic process process that regulates fever generation.


description: The chemical reactions and pathways resulting in the formation of 4-hydroxyphenylacetate.


L-idonate biosynthetic process

description: The chemical reactions and pathways resulting in the formation of L-idonate, the anion of idonic acid, an aldonic acid derived from L-idose, an aldohexose which is epimeric with D-glucose.


indoleacetic acid biosynthetic process

description: The chemical reactions and pathways resulting in the formation of indole-3-acetic acid, a compound which functions as a growth regulator in plants.


cinnamic acid biosynthetic process

description: The chemical reactions and pathways resulting in the formation of cinnamic acid, 3-phenyl-2-propenoic acid.


phaseic acid biosynthetic process

description: The chemical reactions and pathways resulting in the formation of phaseic acid (PA), a catabolite of the plant hormone abscisic acid (ABA).


jasmonic acid biosynthetic process

description: The chemical reactions and pathways resulting in the formation of jasmonic acid, a fatty acid derivative.


name: short-chain fatty acid biosynthetic process

description: The chemical reactions and pathways resulting in the formation of a short-chain fatty acid. A short-chain fatty acid has an aliphatic tail containing fewer than 6 carbons.


propionate biosynthetic process

description: The chemical reactions and pathways resulting in the formation of propionate, the anion derived from propionic acid.


hepoxilin biosynthetic process

description: The chemical reactions and pathways resulting in the formation of hepoxilins, a class of bioactive icosanoids with roles in the regulation of cell physiology.


penicillin biosynthetic process

description: The chemical reactions and pathways resulting in the formation of any antibiotic that contains the condensed beta-lactamthiazolidine ring system.


(R)-mevalonic acid biosynthetic process

description: The chemical reactions and pathways resulting in the formation of (R)-mevalonic acid.


prostaglandin biosynthetic process

description: The chemical reactions and pathways resulting in the formation of prostaglandins, any of a group of biologically active metabolites which contain a cyclopentane ring.


lipoxin B4 biosynthetic process

description: The chemical reactions and pathways resulting in the formation of lipoxin B4. Lipoxin B4 is a C20 hydroxy fatty acid having (5S)-, (14R)- and (15S)-hydroxy groups as well as (6E)- (8Z)-, (10E)- and (12E)-double bonds.


name: cyclic 2,3-bisphospho-D-glycerate biosynthetic process

description: The chemical reactions and pathways resulting in the formation of cyclic 2,3-bisphospho-D-glyceric acid.


D-glucuronate biosynthetic process

description: The chemical reactions and pathways resulting in the formation of D-glucuronate, the D-enantiomer of glucuronate.


biotin biosynthetic process

description: The chemical reactions and pathways resulting in the formation of biotin, cis-tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid.


salicylic acid biosynthetic process

description: The chemical reactions and pathways resulting in the formation of salicylic acid (2-hydroxybenzoic acid), a derivative of benzoic acid.


mandelate biosynthetic process

description: The chemical reactions and pathways resulting in the formation of mandelate, the anion of mandelic acid. Mandelic acid (alpha-hydroxybenzeneacetic acid) is an 8-carbon alpha-hydroxy acid (AHA) that is used in organic chemistry and as a urinary antiseptic.


ferulate biosynthetic process

description: The chemical reactions and pathways resulting in the formation of ferulate, (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate.


name: fatty acid elongation, monounsaturated fatty acid

description: Elongation of a fatty acid chain into which one C-C double bond has been introduced.


name: very long-chain fatty acid biosynthetic process

description: The chemical reactions and pathways resulting in the formation of a very long-chain fatty acid. A very long-chain fatty acid has an aliphatic tail containing more than 22 carbons.


name: D-lactate biosynthetic process from methylglyoxal via (R)-lactaldehyde

description: The chemical reactions and pathways resulting in the formation of D-lactate from methylglyoxal, via the intermediate (R)-lactaldehyde.


clavulanic acid biosynthetic process

description: The chemical reactions and pathways resulting in the formation of clavulanic acid, (2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid.


lipoate biosynthetic process

description: The chemical reactions and pathways resulting in the formation of lipoate, 1,2-dithiolane-3-pentanoate, the anion derived from lipoic acid.


leukotriene A4 biosynthetic process

description: The chemical reactions and pathways resulting in the formation of leukotriene A4.


glycolate biosynthetic process

description: The chemical reactions and pathways resulting in the formation of glycolate, the anion of hydroxyethanoic acid (glycolic acid).


name: butyryl-CoA catabolic process to butyrate

description: The chemical reactions a resulting in the resulting in the breakdown of butyryl-CoA to form butyrate.


protein deglycation, glyoxal removal

description: The removal of glyoxal from a glycated protein, to form glycolate and a deglycated protein.


name: tryptophan-independent indoleacetic acid biosynthetic process

description: The chemical reactions and pathways resulting in the formation of indoleacetic acid, independent of tryptophan.


name: fatty acid elongation, unsaturated fatty acid

description: Elongation of a fatty acid chain into which one or more C-C double bonds have been introduced.


acetoacetic acid biosynthetic process

description: The chemical reactions and pathways resulting in the formation of acetoacetic acid, a beta-keto acid of the keto acid group, empirical formula is C4H6O3 or CH3COCH2COOH.


glucuronate biosynthetic process

description: The chemical reactions and pathways resulting in the formation of glucuronate, the anion of glucuronic acid.


kynurenic acid biosynthetic process

description: The chemical reactions and pathways resulting in the formation of kynurenic acid, 4-hydroxyquinoline-2-carboxylic acid.


abscisic acid biosynthetic process

description: The chemical reactions and pathways resulting in the formation of abscisic acid, 5-(1-hydroxy-2,6,6,trimethyl-4-oxocyclohex-2-en-1-y1)-3-methylpenta-2,4-dienoic acid.


quinate biosynthetic process

description: The chemical reactions and pathways resulting in the formation of quinate, the anion of quinic acid.


formate biosynthetic process

description: The chemical reactions and pathways resulting in the formation of formate, also known as methanoate, the anion HCOO- derived from methanoic (formic) acid.


name: methionine catabolic process to 3-methylthiopropanoate

description: The chemical reactions and pathways involving the catabolism of amino acids to produce carboxylic acids with one carbon less than the starting amino acid. In S. cerevisiae, this is known to occur for leucine, isoleucine, valine, methionine, phenylalanine, tyrosine, or tryptophan. When methionine is used as the substrate, 3-methylthiopropanoate is produced. Often referred to as the Ehrlich pathway, these reactions generally occur during fermentation to produce a variety of carboxylic acids, sometimes collectively referred to as fusel acids. Depending on the redox state of the cells, alcohol derivatives may be produced instead of carboxylic acids.


pyruvate biosynthetic process

description: The chemical reactions and pathways resulting in the formation of pyruvate, 2-oxopropanoate.


name: acetate biosynthetic process from carbon monoxide

description: The chemical reactions and pathways resulting in the formation of acetate from other compounds, including carbon monoxide.


name: medium-chain fatty acid biosynthetic process

description: The chemical reactions and pathways resulting in the formation of a medium-chain fatty acid. A medium-chain fatty acid has an aliphatic tail containing 6 to 12 carbons.


lactate biosynthetic process

description: The chemical reactions and pathways resulting in the formation of lactate, the anion of lactic acid.


name: protein deglycation, methylglyoxal removal

description: The removal of methylglyoxal from a glycated protein, to form lactate and a deglycated protein.


retinoic acid biosynthetic process

description: The chemical reactions and pathways resulting in the biosynthesis of retinoic acid, one of the three components that makes up vitamin A.


name: fatty acid elongation, saturated fatty acid

description: Elongation of a saturated fatty acid chain.


name: 2-dehydro-3-deoxy-D-gluconic acid biosynthetic process

description: The chemical reactions and pathways resulting in the formation of 2-dehydro-3-deoxy-D-gluconic acid.


p-cumate biosynthetic process

description: The chemical reactions and pathways resulting in the formation of p-cumate.


name: L(+)-lactate biosynthetic process from pyruvate

description: The chemical reactions and pathways resulting in the formation of L(+)-lactate from other compounds, including pyruvate.


dethiobiotin biosynthetic process

description: The chemical reactions and pathways resulting in the formation of dethiobiotin, a derivative of biotin in which the sulfur atom has been replaced by two hydrogen atoms.


methylgallate biosynthetic process

description: The chemical reactions and pathways resulting in the formation of methylgallate, trihydroxymethylbenzoate, the anion of methylgallic acid.


name: unsaturated fatty acid biosynthetic process

description: The chemical reactions and pathways resulting in the formation of an unsaturated fatty acid, any fatty acid containing one or more double bonds between carbon atoms.


name: lactate biosynthetic process from pyruvate

description: The chemical reactions and pathways resulting in the formation of lactate from other compounds, including pyruvate.


mycolic acid biosynthetic process

description: The chemical reactions and pathways resulting in the formation of mycolic acids, beta-hydroxy fatty acids with a long alpha-alkyl side chain.


name: positive regulation of fever generation by prostaglandin biosynthetic process

description: Any prostaglandin biosynthetic process process that positively_regulates fever generation.


aldonic acid biosynthetic process

description: The chemical reactions and pathways resulting in the formation of aldonic acid, a monocarboxylic acid with a chain of three or more carbon atoms, derived from an aldose by oxidation of the aldehydic group.


2-oxobutyrate biosynthetic process

description: The chemical reactions and pathways resulting in the formation of 2-oxobutyrate, the anion of the organic acid 2-oxobutyric acid, which contains a ketone group on carbon 2.


butyrate biosynthetic process

description: The chemical reactions and pathways resulting in the formation of butyrate, the anion of butyric acid.


o-orsellinic acid biosynthetic process

description: The chemical reactions and pathways resulting in the formation of o-orsellinic acid.


palmitic acid biosynthetic process

description: The chemical reactions and pathways resulting in the formation of palmitic acid.


ochratoxin A biosynthetic process

description: The chemical reactions and pathways resulting in the formation of ochratoxin A.


glycyrrhetinate biosynthetic process

description: The chemical reactions and pathways resulting in the formation of glycyrrhetinate.


name: cilia- and flagella-associated protein 95 isoform h1 (human)

description: A cilia- and flagella-associated protein 95 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5VTT2-1.


phenylsilane

An organosilicon compound that is benzene in which a hydrogen is replaced by a silyl group.


name: serine/threonine-protein kinase WNK4 isoform h2 (human)

description: A serine/threonine-protein kinase WNK4 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96J92-2.


A glycosylglucose formed by a beta-(1->4)-linkage between D-mannose and D-glucose.


A carbodiimide compound having an isopropyl substituent on both nitrogen atoms.


name: chronic lymphoproliferative disorder of NK-cells

description: An Epstein-Barr virus negative disorder with a chronic clinical course affecting predominantly adults and characterized by the proliferation of large granular lymphocytes with natural killer cell immunophenotype. The T-cell receptor genes are not rearranged.


name: autosomal recessive early-onset Parkinson disease 23

description: Any young-onset Parkinson disease in which the cause of the disease is a mutation in the VPS13C gene.


Parkinson disease

description: A progressive degenerative disorder of the central nervous system characterized by loss of dopamine producing neurons in the substantia nigra and the presence of Lewy bodies in the substantia nigra and locus coeruleus. Signs and symptoms include tremor which is most pronounced during rest, muscle rigidity, slowing of the voluntary movements, a tendency to fall back, and a mask-like facial expression.


Parkinson disease 17

description: Any Parkinson disease in which the cause of the disease is a mutation in the VPS35 gene.


juvenile onset Parkinson disease 19A

description: Any Parkinson disease in which the cause of the disease is a mutation in the DNAJC6 gene.


Parkinson disease 21

description: Any hereditary late onset Parkinson disease in which the cause of the disease is a mutation in the DNAJC13 gene.


Kufor-Rakeb syndrome

description: Kufor-Rakeb syndrome (KRS) is a rare genetic neurodegenerative disorder characterized by juvenile Parkinsonism, pyramidal degeneration (dystonia), supranuclear palsy, and cognitive impairment.


name: autosomal recessive juvenile Parkinson disease 2

description: A group of disorders which feature impaired motor control characterized by bradykinesia, muscle rigidity; tremor; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see parkinson disease), secondary parkinsonism (see parkinson disease, secondary) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the basal ganglia.


early-onset Parkinson disease 20

description: Any Parkinson disease in which the cause of the disease is a mutation in the SYNJ1 gene.


name: parkinson disease 25, autosomal recessive early-onset, with impaired intellectual development


parkinsonian-pyramidal syndrome

description: A Parkinson's disease that has material basis in mutation in the FBXO7 gene on chromosome 22q12.3.


late-onset Parkinson disease

description: A Parkinson disease that begins after around the age of 50.


autosomal dominant Parkinson disease 8

description: Any Parkinson disease in which the cause of the disease is a mutation in the LRRK2 gene.


name: autosomal recessive early-onset Parkinson disease 7

description: Any Parkinson disease in which the cause of the disease is a mutation in the PARK7 gene.


young-onset Parkinson disease

description: A form of Parkinson disease (PD) characterized by an age of onset between 21-45 years, rigidity, painful cramps followed by tremor, bradykinesia, dystonia, gait complaints and falls, and other non-motor symptoms. A slow disease progression and a more pronounced response to dopaminergic therapy are also observed in most YOPD forms.


autosomal dominant Parkinson disease 4

description: A late onset Parkinson disease that has material basis in heterozygous triplication of the alpha-synuclein gene (SNCA) on chromosome 4q22.


autosomal dominant Parkinson disease 1

description: An autosomal dominant subtype of Parkinson disease, caused by mutation(s) in the SNCA gene, encoding alpha-synuclein. Mutation(s) in the SNCA gene are responsible for PARK4 and Lewy body dementia, and have overlapping phenotypes.


name: Parkinson disease 22, autosomal dominant

description: Any Parkinson disease in which the cause of the disease is a mutation in the CHCHD2 gene.


name: autosomal recessive early-onset Parkinson disease 6

description: Any Parkinson disease in which the cause of the disease is a mutation in the PINK1 gene.


name: autosomal recessive Parkinson disease 14

description: A rare neurodegenerative disease usually presenting before the age of 30 and which is characterized by dystonia, L-dopa-responsive parkinsonism, pyramidal signs and rapid cognitive decline.


A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.


hymenolepiasis

description: A parasitic infection caused by tapeworms. Most infected individuals do not have symptoms. When symptoms appear, they include diarrhea, abdominal pain, restlessness, and irritability.


name: lys-63-specific deubiquitinase BRCC36 isoform h3 (human)

description: A lys-63-specific deubiquitinase BRCC36 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P46736-3.


oral candidiasis

description: Infection of the mucosal lining of the mouth with the fungus Candida albicans.


name: E3 ubiquitin-protein ligase TRIP12 isoform h4 (human)

description: An E3 ubiquitin-protein ligase TRIP12 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q14669-4.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant K663Q, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Gln residue at the position equivalent to Lys-663 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Lys-663, CHEBI:30011.


name: receptor-type tyrosine-protein kinase FLT3

description: A CSF-1/PDGF receptor-type tyrosine-protein kinase that is a translation product of the human FLT3 gene or a 1:1 ortholog thereof.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant V579E, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Glu residue at the position equivalent to Val-579 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Val-579, CHEBI:29972.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant K663R, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Arg residue at the position equivalent to Lys-663 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Lys-663, CHEBI:29952.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835V, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Val residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asp-835, CHEBI:30015.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant S451F, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Phe residue at the position equivalent to Ser-451 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Ser-451, CHEBI:29997|Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant Y842H, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a His residue at the position equivalent to Tyr-842 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Tyr-842, CHEBI:29979.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant V579E, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Glu residue at the position equivalent to Val-579 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Val-579, CHEBI:29972|Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048.


name: receptor-type tyrosine-protein kinase FLT3 isoform h2 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P36888-2.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D839H, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a His residue at the position equivalent to Asp-839 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asp-839, CHEBI:29979.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N841Y, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Tyr residue at the position equivalent to Asn-841 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asn-841, CHEBI:46858.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant V579I, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Ile residue at the position equivalent to Val-579 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Val-579, CHEBI:30009.


name: receptor-type tyrosine-protein kinase FLT3, signal peptide removed phosphorylated 2 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has had the signal peptide removed and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969 of the amino acid sequence represented by UniProtKB:P36888-1. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant F594I, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Ile residue at the position equivalent to Phe-594 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Phe-594, CHEBI:30009.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant F691V, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Val residue at the position equivalent to Phe-691 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Phe-691, CHEBI:30015.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant K663N, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Asn residue at the position equivalent to Lys-663 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Lys-663, CHEBI:50347.


name: receptor-type tyrosine-protein kinase FLT3, signal peptide removed phosphorylated and ubiquitinated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has had the signal peptide removed, that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969 of the amino acid sequence represented by UniProtKB:P36888-1, and that includes at least 1 ubiquitinated lysine. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|MOD:01148.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835H, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a His residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asp-835, CHEBI:29979.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D839N, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Asn residue at the position equivalent to Asp-839 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asp-839, CHEBI:50347.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N676T, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Thr residue at the position equivalent to Asn-676 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asn-676, CHEBI:30013.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant V592D, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Asp residue at the position equivalent to Val-592 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Val-592, CHEBI:29958.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D839Q, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Gln residue at the position equivalent to Asp-839 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asp-839, CHEBI:30011.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant F594L, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Leu residue at the position equivalent to Phe-594 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Phe-594, CHEBI:30006.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835N, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Asn residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asp-835, CHEBI:50347.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N676S, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Ser residue at the position equivalent to Asn-676 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asn-676, CHEBI:29999.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N841T, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Thr residue at the position equivalent to Asn-841 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asn-841, CHEBI:30013.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D839N, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Asn residue at the position equivalent to Asp-839 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asp-839, CHEBI:50347.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant F691L, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Leu residue at the position equivalent to Phe-691 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Phe-691, CHEBI:30006.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D839Q, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Gln residue at the position equivalent to Asp-839 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asp-839, CHEBI:30011.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835A, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Ala residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asp-835, CHEBI:46217.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant V579L, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Leu residue at the position equivalent to Val-579 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Val-579, CHEBI:30006|Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant Y842C, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Cys residue at the position equivalent to Tyr-842 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Tyr-842, CHEBI:29950.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N676D, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Asp residue at the position equivalent to Asn-676 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asn-676, CHEBI:29958.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant Y842C, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Cys residue at the position equivalent to Tyr-842 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Tyr-842, CHEBI:29950.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant V592A, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Ala residue at the position equivalent to Val-592 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Val-592, CHEBI:46217.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835F, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Phe residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asp-835, CHEBI:29997.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant Y572C, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Cys residue at the position equivalent to Tyr-572 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Tyr-572, CHEBI:29950.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant A627P, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Pro residue at the position equivalent to Ala-627 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Ala-627, CHEBI:50342.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant F594S, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Ser residue at the position equivalent to Phe-594 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Phe-594, CHEBI:29999.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835A, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Ala residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asp-835, CHEBI:46217.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant V592G, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Gly residue at the position equivalent to Val-592 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Val-592, CHEBI:29947.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant F691I, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Ile residue at the position equivalent to Phe-691 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Phe-691, CHEBI:30009.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D839H, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a His residue at the position equivalent to Asp-839 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asp-839, CHEBI:29979.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N841K, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Lys residue at the position equivalent to Asn-841 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asn-841, CHEBI:29967.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant V579A, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Ala residue at the position equivalent to Val-579 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Val-579, CHEBI:46217|Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835G, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Gly residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asp-835, CHEBI:29947.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant R834Q, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Gln residue at the position equivalent to Arg-834 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Arg-834, CHEBI:30011.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant F621L, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Leu residue at the position equivalent to Phe-621 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Phe-621, CHEBI:30006.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant V592D, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Asp residue at the position equivalent to Val-592 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Val-592, CHEBI:29958.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835G, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Gly residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asp-835, CHEBI:29947.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835E, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Glu residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asp-835, CHEBI:29972.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant F594S, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Ser residue at the position equivalent to Phe-594 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Phe-594, CHEBI:29999.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835Y, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Tyr residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asp-835, CHEBI:46858.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant S451F, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Phe residue at the position equivalent to Ser-451 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Ser-451, CHEBI:29997.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant F594L, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Leu residue at the position equivalent to Phe-594 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Phe-594, CHEBI:30006.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N841H, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a His residue at the position equivalent to Asn-841 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asn-841, CHEBI:29979.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N841Y, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Tyr residue at the position equivalent to Asn-841 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asn-841, CHEBI:46858.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835H, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a His residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asp-835, CHEBI:29979.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant F594V, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Val residue at the position equivalent to Phe-594 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Phe-594, CHEBI:30015.


name: receptor-type tyrosine-protein kinase FLT3, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has had the signal peptide removed. UniProtKB:P36888, 27-993.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835Y, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Tyr residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asp-835, CHEBI:46858.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N676S, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Ser residue at the position equivalent to Asn-676 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asn-676, CHEBI:29999.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant F691V, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Val residue at the position equivalent to Phe-691 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Phe-691, CHEBI:30015.


name: receptor-type tyrosine-protein kinase FLT3, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has had the signal peptide removed and that has been phosphorylated on the residues at the positions equivalent to Tyr-768 and Tyr-969 of the amino acid sequence represented by UniProtKB:P36888-1. Example: UniProtKB:P36888-1, 27-993, Tyr-768/Tyr-969, MOD:00048.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835E, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Glu residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asp-835, CHEBI:29972.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N676K, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Lys residue at the position equivalent to Asn-676 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asn-676, CHEBI:29967.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant A848P, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Pro residue at the position equivalent to Ala-848 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Ala-848, CHEBI:50342.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N841I, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Ile residue at the position equivalent to Asn-841 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asn-841, CHEBI:30009.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835F, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Phe residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asp-835, CHEBI:29997.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835V, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Val residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asp-835, CHEBI:30015.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant V592G, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Gly residue at the position equivalent to Val-592 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Val-592, CHEBI:29947.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N841K, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Lys residue at the position equivalent to Asn-841 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asn-841, CHEBI:29967.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant K663Q, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Gln residue at the position equivalent to Lys-663 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Lys-663, CHEBI:30011.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D839G, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Gly residue at the position equivalent to Asp-839 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asp-839, CHEBI:29947.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant V579I, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Ile residue at the position equivalent to Val-579 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Val-579, CHEBI:30009|Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant Y842H, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a His residue at the position equivalent to Tyr-842 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Tyr-842, CHEBI:29979.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N841T, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Thr residue at the position equivalent to Asn-841 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asn-841, CHEBI:30013.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N841I, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Ile residue at the position equivalent to Asn-841 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asn-841, CHEBI:30009.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N676T, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Thr residue at the position equivalent to Asn-676 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Asn-676, CHEBI:30013.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant F594I, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Ile residue at the position equivalent to Phe-594 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Phe-594, CHEBI:30009.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant K663R, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Arg residue at the position equivalent to Lys-663 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Lys-663, CHEBI:29952.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N841H, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a His residue at the position equivalent to Asn-841 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asn-841, CHEBI:29979.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant N676K, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Lys residue at the position equivalent to Asn-676 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asn-676, CHEBI:29967.


name: receptor-type tyrosine-protein kinase FLT3 isoform h1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P36888-1.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant K663N, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Asn residue at the position equivalent to Lys-663 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Lys-663, CHEBI:50347.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant V592A, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Ala residue at the position equivalent to Val-592 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Val-592, CHEBI:46217.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant V579A, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Ala residue at the position equivalent to Val-579 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Val-579, CHEBI:46217.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant F691L, signal peptide removed phosphorylated 1 (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Leu residue at the position equivalent to Phe-691 of the amino acid sequence represented by UniProtKB:P36888-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-589, Tyr-591, Tyr-599, Tyr-768, Tyr-955, and Tyr-969. Example: UniProtKB:P36888-1, 27-993, Tyr-589/Tyr-591/Tyr-599/Tyr-768/Tyr-955/Tyr-969, MOD:00048|Phe-691, CHEBI:30006.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant V579L, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Leu residue at the position equivalent to Val-579 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Val-579, CHEBI:30006.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant D835N, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has an Asn residue at the position equivalent to Asp-835 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Asp-835, CHEBI:50347.


name: receptor-type tyrosine-protein kinase FLT3 sequence variant F594V, signal peptide removed form (human)

description: A receptor-type tyrosine-protein kinase FLT3 (human) that has a Val residue at the position equivalent to Phe-594 of the amino acid sequence represented by UniProtKB:P36888-1 and that has had the signal peptide removed. Example: UniProtKB:P36888-1, 27-993, Phe-594, CHEBI:30015.


name: Ras-related protein Rab-43 methylated 1 (human)

description: A Ras-related protein Rab-43 (human) that has been methylated on the residue at the position equivalent to Cys-157 of the amino acid sequence represented by UniProtKB:Q86YS6-1. Example: UniProtKB:Q86YS6-1, Cys-157, MOD:00660.


congenital aortic valve insufficiency

description: Dysfunction of the aortic valve characterized by incomplete valve closure that is present at birth.


Heart valve regurgitation

description: Dysfunction of one of the cardiac valves characterized by incomplete valve closure.


mitral valve disorder

description: A disease involving the mitral valve.


Rheumatic tricuspid valve regurgitation

description: Tricuspid valve insufficiency secondary to rheumatic fever.


name: Congenital insufficiency of pulmonary valve

description: Dysfunction of the pulmonary valve characterized by incomplete valve closure that is present at birth.


kalirin isoform r1 (rat)

A kalirin (rat) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P97924-1.


kalirin isoform r5 (rat)

A kalirin (rat) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P97924-5.


kalirin isoform r7 (rat)

A kalirin (rat) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P97924-7.


kalirin isoform r8 (rat)

A kalirin (rat) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P97924-8.


kalirin isoform r4 (rat)

A kalirin (rat) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P97924-4.


kalirin isoform r2 (rat)

A kalirin (rat) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P97924-2.


kalirin isoform 6 (rat)

A kalirin isoform 9 that is encoded in the genome of rat.


kalirin isoform r3 (rat)

A kalirin (rat) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P97924-3.


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and (9Z)-octadec-9-enoyl (oleoyl) respectively.


name: pyroglutamyl-peptidase 1-like protein isoform h1 (human)

description: A pyroglutamyl-peptidase 1-like protein (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:A6NFU8-1.


name: NPL4_SCHPO Nuclear protein localization protein 4 (sprot)

description: A nuclear protein localization protein 4 that is encoded in the genome of Schizosaccharomyces pombe 972h-.


YEGI_ECOLI Protein kinase YegI (sprot)

A protein kinase YegI that is encoded in the genome of Escherichia coli K-12.


name: very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 1 isoform h2 (human)

description: A very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:B0YJ81-2.


name: smad2 isoform Long phosphorylated 4 (human)

description: A smad2 isoform Long phosphorylated 4 in human. This form is phosphorylated at the clusters of [S/T]P motifs within the MH1-MH2 domain linker region. UniProtKB:Q15796-1, Thr-220, MOD:00047|Ser-245/Ser-250/Ser-255, MOD:00046.


smad2 isoform Long phosphorylated 4

A smad2 isoform Long phosphorylated form in which the phosphorylation occurs at the clusters of [S/T]P motifs within the MH1-MH2 domain linker region through the MAP kinase cascade in the oncogenic Ras-activated pathway. Example: UniProtKB:Q15796-1, Thr-220, MOD:00047|Ser-245/Ser-250/Ser-255, MOD:00046.


name: leucine-rich repeat-containing protein 27 isoform h4 (human)

description: A leucine-rich repeat-containing protein 27 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9C0I9-4.


name: SYQ_CAEEL Probable glutamine--tRNA ligase (sprot)

description: A glutamine--tRNA ligase that is encoded in the genome of worm.


name: protein HEG homolog 1 O-glycosylated 21 (human)

description: A protein HEG homolog 1 (human) that has been O-glycosylated at the residue equivalent to Thr-492 of the amino acid sequence represented by UniProtKB:Q9ULI3-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q9ULI3-1, Thr-492, MOD:00005~GNO:G43417UB.


name: nuclear factor 1 A-type isoform m1 (mouse)

description: A nuclear factor 1 A-type (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q02780-2.


name: collagen alpha-2(V) chain, signal peptide removed 4-hydroxy-proline and glucosylgalactosylhydroxylysine form (human)

description: A collagen alpha-2(V) chain (human) that has had the signal peptide removed and that includes at least 1 glucosylgalactosylhydroxylated lysine and at least 3 4-hydroxy-prolines. UniProtKB:P05997, 27-1499, MOD:00039(3+)|MOD:00162.


collagen alpha-2(V) chain

A collagen type V alpha chain that is a translation product of the human COL5A2 gene or a 1:1 ortholog thereof.


name: collagen alpha-2(V) chain, signal peptide removed form (human)

description: A collagen alpha-2(V) chain (human) that has had the signal peptide removed. UniProtKB:P05997, 27-1499.


name: collagen alpha-2(V) chain O-glycosylated 1 (human)

description: A collagen alpha-2(V) chain (human) that has been O-glycosylated at the residue equivalent to Ser-188 of the amino acid sequence represented by UniProtKB:P05997-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05997-1, Ser-188, MOD:00002~GNO:G43417UB.


name: collagen alpha-2(V) chain isoform 1 (human)

description: A collagen alpha-2(V) chain isoform 1 that is encoded in the genome of human.


name: collagen alpha-2(V) chain deaminated 1 (human)

description: A collagen alpha-2(V) chain (human) that has been deaminated on the residue at the position equivalent to Gln-1099 of the amino acid sequence represented by UniProtKB:P05997. UniProtKB:P05997, Gln-1099, MOD:00685.


name: collagen alpha-2(V) chain, signal peptide removed 5-hydroxy-lysine, 3-hydroxy-proline and 4-hydroxy-proline form (human)

description: A collagen alpha-2(V) chain (human) that has had the signal peptide removed and that includes at least one 5-hydroxy-lysine, at least one 3-hydroxy-proline and at least one 4-hydroxy-proline. UniProtKB:P05997, 27-1499, MOD:00037|MOD:00038|MOD:00039.


name: CO5A2_MOUSE Collagen alpha-2(V) chain (sprot)

description: A collagen alpha-2(V) chain that is encoded in the genome of mouse.


collagen alpha-2(V) chain isoform 1

A collagen alpha-2(V) chain that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P05997-1 or a 1:1 ortholog thereof.


name: collagen alpha-2(V) chain, signal peptide removed 3-hydroxy-proline and 4-hydroxy-proline form (human)

description: A collagen alpha-2(V) chain (human) that has had the signal peptide removed and that includes at least one 3-hydroxy-proline and at least one 4-hydroxy-proline. UniProtKB:P05997, 27-1499, MOD:00038|MOD:00039.


name: collagen alpha-2(V) chain, signal peptide removed glucosylgalactosylhydroxylysine form (human)

description: A collagen alpha-2(V) chain (human) that has had the signal peptide removed and that includes at least 1 glucosylgalactosylhydroxylated lysine. UniProtKB:P05997, 27-1499, MOD:00162.


name: collagen alpha-2(V) chain, signal peptide removed 5-hydroxy-lysine and 4-hydroxy-proline form (human)

description: A collagen alpha-2(V) chain (human) that has had the signal peptide removed and that includes at least one 5-hydroxy-lysine and at least one 4-hydroxy-proline. UniProtKB:P05997, 27-1499, MOD:00037|MOD:00039.


name: collagen alpha-2(V) chain, signal peptide removed 3-hydroxy-proline, 4-hydroxy-proline, and glucosylgalactosylhydroxylysine form (human)

description: A collagen alpha-2(V) chain (human) that has had the signal peptide removed and that includes at least 1 3-hydroxy-proline, at least 1 glucosylgalactosylhydroxylated lysine, and at least 3 4-hydroxy-prolines. UniProtKB:P05997, 27-1499, MOD:00038|MOD:00039(3+)|MOD:00162.


name: collagen alpha-2(V) chain 5-hydroxy-lysine, 3-hydroxy-proline and 4-hydroxy-proline form (human)

description: A collagen alpha-2(V) chain (human) that includes at least one 5-hydroxy-lysine, at least one 3-hydroxy-proline and at least one 4-hydroxy-proline. UniProtKB:P05997, MOD:00037|MOD:00038|MOD:00039.


name: collagen alpha-2(V) chain 5-hydroxy-lysine and 4-hydroxy-proline form (human)

description: A collagen alpha-2(V) chain (human) that includes at least one 5-hydroxy-lysine and at least one 4-hydroxy-proline. UniProtKB:P05997, MOD:00037|MOD:00039.


name: collagen alpha-2(V) chain, signal peptide removed galactosylhydroxylysine form (human)

description: A collagen alpha-2(V) chain (human) that has had the signal peptide removed and that includes at least 1 galactosylhydroxylated lysine. UniProtKB:P05997, 27-1499, MOD:01914.


name: collagen alpha-2(V) chain, signal peptide removed form

description: A collagen alpha-2(V) chain that has had the signal peptide removed.


name: collagen alpha-2(V) chain, signal peptide removed 4-hydroxy-proline form (human)

description: A collagen alpha-2(V) chain (human) that has had the signal peptide removed and that includes at least one 4-hydroxy-proline. UniProtKB:P05997, 27-1499, MOD:00039.


name: collagen alpha-2(V) chain, signal peptide removed 5-hydroxy-lysine form (human)

description: A collagen alpha-2(V) chain (human) that has had the signal peptide removed and that includes at least one 5-hydroxy-lysine. UniProtKB:P05997, 27-1499, MOD:00037.


name: collagen alpha-2(V) chain, signal peptide removed 3-hydroxy-proline, 4-hydroxy-proline, and galactosylhydroxylysine form (human)

description: A collagen alpha-2(V) chain (human) that has had the signal peptide removed and that includes at least 1 3-hydroxy-proline, at least 1 galactosylhydroxylated lysine, and at least 3 4-hydroxy-prolines. UniProtKB:P05997, 27-1499, MOD:00038|MOD:00039(3+)|MOD:01914.


name: collagen alpha-2(V) chain 5-hydroxy-lysine form (human)

description: A collagen alpha-2(V) chain (human) that includes at least one 5-hydroxy-lysine. UniProtKB:P05997, MOD:00037.


name: collagen alpha-2(V) chain 3-hydroxy-proline and 4-hydroxy-proline form (human)

description: A collagen alpha-2(V) chain (human) that includes at least one 3-hydroxy-proline and at least one 4-hydroxy-proline. UniProtKB:P05997, MOD:00038|MOD:00039.


name: collagen alpha-2(V) chain 4-hydroxy-proline form (human)

description: A collagen alpha-2(V) chain (human) that includes at least one 4-hydroxy-proline. UniProtKB:P05997, MOD:00039.


name: collagen alpha-2(V) chain, signal peptide removed 4-hydroxy-proline and galactosylhydroxylysine form (human)

description: A collagen alpha-2(V) chain (human) that has had the signal peptide removed and that includes at least 1 galactosylhydroxylated lysine and at least 3 4-hydroxy-prolines. UniProtKB:P05997, 27-1499, MOD:00039(3+)|MOD:01914.


name: CO5A2_HUMAN Collagen alpha-2(V) chain (sprot)

description: A collagen alpha-2(V) chain that is encoded in the genome of human.


name: collagen alpha-2(V) chain proteolytic cleavage product

description: A collagen alpha-2(V) chain that has been processed by proteolytic cleavage.


monocaffeoylaltraric acid

An alkyl caffeate ester that is a alkyl caffeate ester.


name: retinol dehydrogenase 10 isoform 1 (human)

description: A retinol dehydrogenase 10 isoform 1 that is encoded in the genome of human.


name: Rab GTPase-binding effector protein 1 deaminated 1 (human)

description: A Rab GTPase-binding effector protein 1 (human) that has been deaminated on the residue at the position equivalent to Gln-663 of the amino acid sequence represented by UniProtKB:Q15276-1. Example: UniProtKB:Q15276-1, Gln-663, MOD:00685.


name: forkhead box protein O isoform A (fruit fly)

description: A forkhead box protein O (fruit fly) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q95V55-2.


name: forkhead box protein O isoform E (fruit fly)

description: A forkhead box protein O (fruit fly) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q95V55-4.


name: forkhead box protein O isoform B (fruit fly)

description: A forkhead box protein O (fruit fly) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q95V55-1.


name: forkhead box protein O isoform D (fruit fly)

description: A forkhead box protein O (fruit fly) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q95V55-3.


name: ADP1_YEAST Probable ATP-dependent permease (sprot)

description: A protein that is a translation product of the ADP1 gene in yeast.


delphilin isoform 1 (human)

A delphilin isoform 1 that is encoded in the genome of human.


name: amyloid-beta precursor protein isoform L-APP752, signal peptide removed form

description: An amyloid-beta precursor protein isoform L-APP752 that has had the signal peptide removed.


A sialononaosylceramide having alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-[alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)]-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc as the sialononaosyl component.


A Delta(4)-beta-D-GlcpA-(1->4)-D-Glcp in which the the carbon bearing the anomeric hydroxy group has alpha- configuration.


An oligosaccharide sufate consisting of alpha-L-threo-hex-4-enopyranuronic acid and 2-acetamido-2-deoxy-6-O-sulfo-D-glucopyranose joined in sequence by a (1->4) glycosidic bond.


name: TM247_HUMAN Transmembrane protein 247 (sprot)

description: A transmembrane protein 247 that is encoded in the genome of human.


transmembrane protein 247

A protein that is a translation product of the human TMEM247 gene or a 1:1 ortholog thereof.


name: TM247_MOUSE Transmembrane protein 247 (sprot)

description: A transmembrane protein 247 that is encoded in the genome of mouse.


name: Golgi-associated plant pathogenesis-related protein 1 isoform 1 (human)

description: A Golgi-associated plant pathogenesis-related protein 1 isoform 1 that is encoded in the genome of human.


name: CXA3_MOUSE Gap junction alpha-3 protein (sprot)

description: A gap junction alpha-3 protein that is encoded in the genome of mouse.


name: single-strand DNA endonuclease 1 isoform 2 (Arabidopsis thaliana)

description: A single-strand DNA endonuclease 1 (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9M2Z3-2.


name: URGT6_ARATH UDP-rhamnose/UDP-galactose transporter 6 (sprot)

description: A protein that is a translation product of the URGT6 gene in Arabidopsis thaliana.


name: transmembrane emp24 domain-containing protein 10 isoform 1 (mouse)

description: A transmembrane emp24 domain-containing protein 10 isoform 1 that is encoded in the genome of mouse.


lateral sinus thrombosis

description: Formation or presence of a blood clot (thrombus) in the lateral sinuses. This condition is often associated with ear infections (otitis media or mastoiditis) without antibiotic treatment. In developed nations, lateral sinus thrombosis can result from craniocerebral trauma; brain neoplasms; neurosurgical procedures; thrombophilia; and other conditions. Clinical features include headache; vertigo; and increased intracranial pressure.


intracranial sinus thrombosis

description: Formation or presence of a blood clot (thrombus) in the cranial sinuses, large endothelium-lined venous channels situated within the skull. Intracranial sinuses, also called cranial venous sinuses, include the superior sagittal, cavernous, lateral, petrous sinuses, and many others. Cranial sinus thrombosis can lead to severe headache; seizure; and other neurological defects.


sagittal sinus thrombosis

description: Formation or presence of a blood clot (thrombus) in the superior sagittal sinus or the inferior sagittal sinus. Sagittal sinus thrombosis can result from infections, hematological disorders, craniocerebral trauma; and neurosurgical procedures. Clinical features are primarily related to the increased intracranial pressure causing headache; nausea; and vomiting. Severe cases can evolve to seizures or coma.


cavernous sinus thrombosis

description: Formation or presence of a blood clot (thrombus) in the cavernous sinus of the brain. Infections of the paranasal sinuses and adjacent structures, craniocerebral trauma, and thrombophilia are associated conditions. Clinical manifestations include dysfunction of cranial nerves iii, iv, V, and vi, marked periorbital swelling, chemosis, fever, and visual loss. (From Adams et al., Principles of Neurology, 6th ed, p711)


Arteriovenous fistula stenosis

description: Narrowing of the lumen of an arteriovenous fistula.


neuferricin isoform 1 (rat)

A neuferricin isoform 1 that is encoded in the genome of rat.